资讯
GRI Bio reached an interim enrollment goal for a clinical trial testing GRI-0621, a therapy targeting natural killer T-cells ...
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...
Find Gene Editing Therapy Latest News, Videos & Pictures on Gene Editing Therapy and see latest updates, news, information from NDTV.COM. Explore more on Gene Editing Therapy.
The dark chocolate biscuits triggered the key fullness hormone GLP-1 - which is the target of appetite-suppressing injections ...
The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...
COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule medicines for obesity, type 2 diabetes and other ...
Giving obese children weight-loss jabs is effective and helps prevent battles around mealtimes, researchers say. Experts at ...
6 天
News-Medical.Net on MSNTirzepatide outperforms semaglutide for weight loss in people without diabetesBy Vijay Kumar MalesuA major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping obesity treatment strategies and offering new ...
Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...
A “transformational” new study has uncovered the potential of GLP-1 jabs over and above their use for weight loss. Obesity is ...
Obesity is linked to 13 different cancers. Scientists have long known that losing weight can slash the risk of cancer, but ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果